Stocks
Haemonetics CorporationHAE
NYSEHealthcareMedical Devices$59.92+0.72%
A global provider of blood management solutions, specializing in devices and software for blood collection, transfusion, and cellular therapy. The company is a key player in the healthcare supply chain, with a focus on improving efficiency and safety in blood-related procedures. Investors monitor its performance due to its role in addressing critical healthcare needs and its recurring revenue model.
Market Cap: $2.8B52W Range: $47.32 – $87.32
Congressional Interest in Haemonetics Corporation (HAE)
5 members of Congress have disclosed 22 trades in Haemonetics Corporation (HAE), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
5
Buys
12
Sells
9
Who in Congress Is Trading HAE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-05-07 | Lois Frankel | sell | $1K – $15K |
| 2021-05-06 | Lois Frankel | sell | $1K – $15K |